Buy Piramal Enterprises; target of Rs 40: Motilal Oswal
Motilal Oswal is bullish on Piramal Enterprises recommended buy rating on the stock with a target price of Rs 40 in its research report dated June 28, 2020.30-06-2020
Buy Piramal Enterprises; target of Rs 40: Motilal Oswal
Motilal Oswal is bullish on Piramal Enterprises recommended buy rating on the stock with a target price of Rs 40 in its research report dated June 28, 2020.Piramal Enterprises shares gain over 3% after stake sale to Carlyle Group
After touching an intraday high of 1399.95 apiece on the BSE, the scrip closed at 1387.45.The capital raise will accelerate Piramal Pharma's organic and inorganic growth plansPiramal Enterprises to divest 20% in pharma business to Carlyle group
Charts growth plans for pharma, step closer to listingPIRAMAL ENTERPRISES LTD. - 500302 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations') And Securities And Exchange Board Of India'S Circular No. CIR/CFD/CMD/4/2015 Dated September 9, 2015
We had, vide our letter dated 20th June, 2020, made a disclosure regarding acquisition of 100% stake in G&W; PA Laboratories LLC ('G&W; PA') in an all-cash deal for a total consideration of USD 17.5 million by one of the affiliates of the Company ('Transaction'). We wish to inform you that the Company, through its affiliates, has completed the acquisition of G&W; PA on 26th June, 2020 and the Transaction is now closed. This is for your information and records.PIRAMAL ENTERPRISES LTD. - 500302 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations') and Securities and Exchange Board of India's circular no. CIR/CFD/CMD/4/2015 dated September 9, 2015Piramal Enterprises raises 2,590 cr debt from US firm
Money was raised via issuance of three-year NCDs at a rate of 9% to Farallon Capital.PiramaL group has taken several steps in the past six months to manage its liquidityPIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015PIRAMAL ENTERPRISES LTD. - 500302 - Announcement under Regulation 30 (LODR)-Allotment
Kindly refer to our letter dated 23rd June, 2020 on the subject. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that at the Meeting of Administrative Committee of the Board of Directors of the Company held today, the Committee approved the allotment of 25,900 unlisted, senior, secured, rated, redeemable non-convertible bonds each having a face value of Rs.10,00,000/-, aggregating to Rs. 2,590 crores on private placement basis. Kindly take the above on record and oblige.PIRAMAL ENTERPRISES LTD. - 500302 - Intimation Under Regulation 57 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Piramal Enterprises to raise up to Rs 2,590 crore
The tenure of the instrument is three-years-and-one day and the interest rate is fixed at 9 per cent per annum.